Karyopharm Therapeutics Inc. · NASDAQ:KPTI

Paulson Richard A. sold 2,203 Karyopharm Therapeutics Inc. shares (Form 4)

Traded May 13 to May 14, 2026 · Filed May 15, 2026

From May 13 to May 14, 2026, Paulson Richard A. (Director, President and CEO) sold 2,203 Karyopharm Therapeutics Inc. shares at US$9.50 for US$20,929, leaving 269,747 shares. Filed May 15, 2026 (Form 4).

Sold
2,203 shares
Price
US$9.50
Value
US$20,929
Holding after
269,747 shares
Trading plan
No
Role
Director, President and CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 13, 2026Common StockAward4,920271,950Direct
May 14, 2026Common StockSale2,203US$9.50269,747Direct

Source

View original at SEC

Related